Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,967 public trials 1,828 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD

NCT06636487

Conditions
Asthma Bronchiale, Bronchial Diseases, Bronchiectasis, +14 more
Locations
  • Copenhagen University Center, Amager Copenhagen, Greater Copenhagen, Denmark
  • Copenhagen University Center, Frederiksberg-Bispebjerg Copenhagen, Greater Copenhagen, Denmark
  • Copenhagen University Center, Hvidovre Copenhagen, Greater Copenhagen, Denmark
  • Copenhagen University Center, Herlev-Gentofte Gentofte Municipality, Greater Copenhagen, Denmark
View Trial Details
Active, Not Recruiting

Tislelizumab, Gemcitabine and Cisplatin for R/R Hodgkin Lymphoma Followed by Tislelizumab Consolidation in Patients in Metabolic Complete Remission

NCT05502250

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • BE-Bruxelles-STLUC Brussels, Belgium
  • DK-Aarhus N-AUH Aarhus, Denmark
  • DK-Copenhagen-RIGSHOSPITALET Copenhagen, Denmark
  • DK-Odense-OUH Odense, Denmark
View all 15 locations
View Trial Details
Active, Not Recruiting

Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients

NCT05306301

Conditions
Chemotherapy, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Ematologia con Unità di Trapianto Avellino, AV, Italy
  • Ematologia Presidio Ospedaliero Tortora Pagani, SA, Italy
  • Ematologia ASST Papa Giovanni XXIII Bergamo, Italy
  • Ematologia AOU S.ORSOLA-MALPIGHI Bologna, Italy
View all 24 locations
View Trial Details
Active, Not Recruiting

Zanubrutinib in Primary Cold Agglutinin Disease

NCT06067048

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • UZ leuven Leuven, Belgium
  • AZ Delta Roeselare, Belgium
  • Rigshospitalet Copenhagen, Denmark
  • Odense University Hospital Odense, Denmark
View Trial Details
Active, Not Recruiting

A Phase 1, Open-label, Multicenter, Dose Escalation Study of IBI363 (PD1-IL2m) in Subjects With Advanced Solid Malignancies or Lymphomas

NCT05290597

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • [email protected] Sydney, New South Wales, Australia
  • Westmead Hospital Sydney, New South Wales, Australia
  • Sydney Southwest Private Hospital Sydney, New South Wales, Australia
  • Cancer Care Wollongong Sydney, New South Wales, Australia
View Trial Details

Related conditions